Ads
related to: zantac generic brand
Search results
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 2 weeks agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
GSK soothes investors by settling first Zantac cancer lawsuit due for US trial
Reuters via Yahoo Finance· 12 months agoGSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer,...
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo Finance· 2 years agoDrugmakers GSK Plc, Pfizer Inc, Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...
First Zantac cancer risk trial in Calif. postponed five months
Reuters via Yahoo News· 1 year ago(Reuters) -The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer,...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
GSK settles another California lawsuit on heartburn drug Zantac
Reuters via Yahoo News· 8 months agoGSK on Wednesday said it agreed to settle another lawsuit in California alleging its discontinued...
Sanofi sees decision on Zantac dispute with Boehringer in Q1 at earliest
Reuters via Yahoo Finance· 1 year agoPARIS (Reuters) -French drugmaker Sanofi said on Wednesday its dispute with Germany's Boehringer...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines...